- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02026622
Comparative Study of Physiological and Cerebrovascular Reactivity in Depression, at the Three Phases of Emotion (EMPHILINE)
August 31, 2015 updated by: University Hospital, Tours
The main objective is to compare the physiological reactivity (heart and respiratory rates, galvanic skin response, cerebral perfusion, and startle) in the three phases of emotion between depressive subjects, subjects remitted from depression and control subjects.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
76
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tours, France, 37044
- University Hospital of Tours
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Female between 18 and 55
- Informed consent form signed
- Affiliated to a medical insurance
- visual and hearing abilities suitable for exams
- for the depressive group (group D): major depressive disorder according to the DSM-IV criteria as evaluated by the MINI test and MADRS score ≥22
- for the depressive patients in remission's group (group R) : matched on age, at least 1 history of major depressive disorder in the last 10 years and solved for more than 6 months, and MADRS score < 9
- for the control subjects (group T) : matched on age, no psychiatric history, MADRS score < 9
Exclusion Criteria:
- psychotic disorder, bipolar disorder, addiction, suspected dementia (MMSE<25)
- current betablockers or neuroleptics treatment
- any current organic unstable pathology
- history of serious cardiovascular disease (coronary syndrome, cardiac arrythmia, etc.)
- smoking > 10 PY
- history of serious neurologic disease (stroke, cerebral tumour, serious cranial trauma, headache, ...)
- contra-indication to MRI
- uncorrected vision or audition troubles
- patient under juridic protection
- pregnancy, lactating or female without reliable contraception
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: 3 groups of subjects
3 groups: depressive subjects, subjects remitted from depression and control subjects, with the same interventions. psychometric tests, MRI, transcranial doppler and TPI, explicitative interview |
NEO-PI, MADRS, MINI depression, MMSE, STAI-E, ERD, Anhedonia
ASL, rest f-MRI, FLAIR, white matter hyper intensities load
transcranial doppler TPI
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
amplitude variations of heart and respiratory rate, cerebral pulsatility, galvanic skin response and startle as measure of physiological reactivity
Time Frame: one day
|
amplitude variations of heart and respiratory rate, cerebral pulsatility, galvanic skin response and startle.
|
one day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MRI data as measure of cerebral perfusion, volume of leukoaraiosis and default network (fMRI at rest)
Time Frame: one day
|
cerebral perfusion measured by MRI (Arterial Spin Labelling) volume of leukoaraiosis default network (fMRI at rest)
|
one day
|
ultrasound data of doppler as measure of cerebral pulstility
Time Frame: one day
|
doppler index of middle cerebral artery At the same time, heart rate variability and cerebral pulsatility at rest will be collected
|
one day
|
score of psychometric tests as measure of emotional state
Time Frame: one day
|
MADRS score, ERD score, STAI-E score, anhedonia score, Neo-PI score, and the subjective assessment of emotional arousal (self Manikin assessment).
|
one day
|
spontaneous verbal production to emotional pictures and explicitative interviews
Time Frame: one day
|
spontaneous verbal production to emotional pictures and explicitative interviews
|
one day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2013
Primary Completion (Actual)
May 1, 2015
Study Completion (Actual)
August 1, 2015
Study Registration Dates
First Submitted
October 29, 2013
First Submitted That Met QC Criteria
December 31, 2013
First Posted (Estimate)
January 3, 2014
Study Record Updates
Last Update Posted (Estimate)
September 1, 2015
Last Update Submitted That Met QC Criteria
August 31, 2015
Last Verified
August 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PHAO 2012 - TD / EMPHILINE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depressive Disorder
-
Shalvata Mental Health CenterUnknownMAjor Depressive DisorderIsrael
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDDIndia
-
Gangnam Severance HospitalCompletedMajor Depressive Disorder(MDD)Korea, Republic of
-
University College, LondonCompletedUnipolar Major Depressive DisorderUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...Fondo de Investigacion SanitariaUnknown
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDD)India
-
Repurposed Therapeutics, Inc.Unknown
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)United States
-
AccexibleRecruitingMajor Depressive Disorder (MDD)Spain
Clinical Trials on psychometric tests
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell UniversityActive, not recruitingGlioblastoma | Brain CancerUnited States
-
University Hospital FreiburgHeidelberg University; Gono Bishwabidyalay; Gonoshasthaya KendraNot yet recruitingHypertension | Diabetes Mellitus | Depressive Symptoms | Post Traumatic Stress Disorder
-
Assistance Publique - Hôpitaux de ParisRecruitingSleep Deprivation | FATIGUEFrance
-
Central Hospital, Nancy, FranceCompleted
-
University of ArkansasUniversity Hospital, Geneva; Université de MontréalTerminatedHepatic Encephalopathy | Cirrhosis | Refractory Ascites | Hepatic HydrothoraxUnited States, Canada, Switzerland
-
Assiut UniversityCompletedCognitive Dysfunction | Hypercholesterolemia | HyperhomocysteinemiaEgypt
-
Heinrich-Heine University, DuesseldorfGerman Cancer AidNot yet recruitingProstate Cancer | Familial Prostate Cancer
-
Neuromed IRCCSEnrolling by invitationStroke | Epilepsy | Multiple Sclerosis | Parkinson Disease | DementiaItaly
-
Hitit UniversityCompleted
-
Medical University of GrazRecruitingFamily Caregivers | Palliative PatientsAustria